Diphenhydramine Hydrochloride Tablet
Product Images NDC 17714-135

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diphenhydramine Hydrochloride (NDC 17714-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advance Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

De0b674c-figure-01 (De0b674c Figure 01)

Label for Diphenhydramine Hydrochloride 25 mg oral tablets, an antihistamine product by Advance Pharmaceutical Inc. The label highlights 100 mini tablets, noting relief of symptoms such as runny nose, sneezing, itchy nose or throat, and itchy watery eyes. It includes Drug Facts summarizing active ingredient, uses, warnings, and manufacturer details, along with a barcode and lot number/expiration date fields.*

FDA Label Image

De0b674c-figure-02 (De0b674c Figure 02)

Drug Facts panel continuation for Diphenhydramine Hydrochloride 25 mg oral tablets by Advance Pharmaceutical Inc. It includes warnings about drowsiness, alcohol interaction, cautions for children and pregnant or breastfeeding individuals, dosage directions, other tablet ingredients, and a contact number for questions from 8:30 am to 4:30 pm ET, Monday through Friday.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.